Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

56 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Biodegradable- Versus Durable-Polymer Drug-Eluting Stents for STEMI: Final 2-Year Outcomes of the BIOSTEMI Trial.
Pilgrim T, Muller O, Heg D, Roffi M, Kurz DJ, Moarof I, Weilenmann D, Kaiser C, Tapponnier M, Losdat S, Eeckhout E, Valgimigli M, Jüni P, Windecker S, Iglesias JF. Pilgrim T, et al. Among authors: losdat s. JACC Cardiovasc Interv. 2021 Mar 22;14(6):639-648. doi: 10.1016/j.jcin.2020.12.011. JACC Cardiovasc Interv. 2021. PMID: 33727005 Free article. Clinical Trial.
Biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents in patients with ST-segment elevation myocardial infarction (BIOSTEMI): a single-blind, prospective, randomised superiority trial.
Iglesias JF, Muller O, Heg D, Roffi M, Kurz DJ, Moarof I, Weilenmann D, Kaiser C, Tapponnier M, Stortecky S, Losdat S, Eeckhout E, Valgimigli M, Odutayo A, Zwahlen M, Jüni P, Windecker S, Pilgrim T. Iglesias JF, et al. Among authors: losdat s. Lancet. 2019 Oct 5;394(10205):1243-1253. doi: 10.1016/S0140-6736(19)31877-X. Epub 2019 Sep 2. Lancet. 2019. PMID: 31488372 Clinical Trial.
In vivo relationship between near-infrared spectroscopy-detected lipid-rich plaques and morphological plaque characteristics by optical coherence tomography and intravascular ultrasound: a multimodality intravascular imaging study.
Zanchin C, Ueki Y, Losdat S, Fahrni G, Daemen J, Ondracek AS, Häner JD, Stortecky S, Otsuka T, Siontis GCM, Rigamonti F, Radu M, Spirk D, Kaiser C, Engstrom T, Lang I, Koskinas KC, Räber L. Zanchin C, et al. Among authors: losdat s. Eur Heart J Cardiovasc Imaging. 2021 Jun 22;22(7):824-834. doi: 10.1093/ehjci/jez318. Eur Heart J Cardiovasc Imaging. 2021. PMID: 31990323
Validation of the Academic Research Consortium for High Bleeding Risk (ARC-HBR) criteria in patients undergoing percutaneous coronary intervention and comparison with contemporary bleeding risk scores.
Ueki Y, Bär S, Losdat S, Otsuka T, Zanchin C, Zanchin T, Gragnano F, Gargiulo G, Siontis GCM, Praz F, Lanz J, Hunziker L, Stortecky S, Pilgrim T, Heg D, Valgimigli M, Windecker S, Räber L. Ueki Y, et al. Among authors: losdat s. EuroIntervention. 2020 Aug 28;16(5):371-379. doi: 10.4244/EIJ-D-20-00052. EuroIntervention. 2020. PMID: 32065586 Free article.
Relationship between arterial remodelling and serial changes in coronary atherosclerosis by intravascular ultrasound: an analysis of the IBIS-4 study.
Koskinas KC, Maldonado R, Garcia-Garcia HM, Yamaji K, Taniwaki M, Ueki Y, Otsuka T, Zanchin C, Karagiannis A, Radu Juul Jensen MD, Losdat S, Zaugg S, Windecker S, Räber L. Koskinas KC, et al. Among authors: losdat s. Eur Heart J Cardiovasc Imaging. 2021 Aug 14;22(9):1054-1062. doi: 10.1093/ehjci/jeaa221. Eur Heart J Cardiovasc Imaging. 2021. PMID: 32929461
Ultrathin-Strut Versus Thin-Strut Drug-Eluting Stents for Primary PCI: A Subgroup Analysis of the BIOSTEMI Randomized Trial.
Iglesias JF, Muller O, Losdat S, Roffi M, Kurz DJ, Weilenmann D, Kaiser C, Valgimigli M, Windecker S, Pilgrim T. Iglesias JF, et al. Among authors: losdat s. JACC Cardiovasc Interv. 2020 Oct 12;13(19):2314-2316. doi: 10.1016/j.jcin.2020.07.038. JACC Cardiovasc Interv. 2020. PMID: 33032722 Free article. Clinical Trial. No abstract available.
Multivessel percutaneous coronary intervention with thin-strut biodegradable versus durable polymer drug-eluting stents in ST-segment elevation myocardial infarction: A subgroup analysis of the BIOSTEMI randomized trial.
Iglesias JF, Muller O, Losdat S, Roffi M, Kurz DJ, Weilenmann D, Kaiser C, Heg D, Valgimigli M, Windecker S, Pilgrim T. Iglesias JF, et al. Among authors: losdat s. Int J Cardiol. 2021 Jul 1;334:37-41. doi: 10.1016/j.ijcard.2021.04.034. Epub 2021 Apr 20. Int J Cardiol. 2021. PMID: 33887341 Free article. Clinical Trial.
Quantitative Flow Ratio to Predict Nontarget Vessel-Related Events at 5 Years in Patients With ST-Segment-Elevation Myocardial Infarction Undergoing Angiography-Guided Revascularization.
Bär S, Kavaliauskaite R, Ueki Y, Otsuka T, Kelbæk H, Engstrøm T, Baumbach A, Roffi M, von Birgelen C, Ostojic M, Pedrazzini G, Kornowski R, Tüller D, Vukcevic V, Magro M, Losdat S, Windecker S, Räber L. Bär S, et al. Among authors: losdat s. J Am Heart Assoc. 2021 May 4;10(9):e019052. doi: 10.1161/JAHA.120.019052. Epub 2021 Apr 26. J Am Heart Assoc. 2021. PMID: 33899509 Free PMC article. Clinical Trial.
Effects of the PCSK9 antibody alirocumab on coronary atherosclerosis in patients with acute myocardial infarction: a serial, multivessel, intravascular ultrasound, near-infrared spectroscopy and optical coherence tomography imaging study-Rationale and design of the PACMAN-AMI trial.
Zanchin C, Koskinas KC, Ueki Y, Losdat S, Häner JD, Bär S, Otsuka T, Inderkum A, Jensen MRJ, Lonborg J, Fahrni G, Ondracek AS, Daemen J, van Geuns RJ, Iglesias JF, Matter CM, Spirk D, Juni P, Mach F, Heg D, Engstrom T, Lang I, Windecker S, Räber L. Zanchin C, et al. Among authors: losdat s. Am Heart J. 2021 Aug;238:33-44. doi: 10.1016/j.ahj.2021.04.006. Epub 2021 May 2. Am Heart J. 2021. PMID: 33951415 Clinical Trial.
56 results